On behalf of the Champalimaud Research Programme on Digital Therapeutics led by Dr. John Krakauer and Dr. Joe Paton, we'd like to invite you to the workshop on interactive AI systems. At Digital Therapeutics group, our mission is to leverage cutting-edge technology to create evidence-based, personalised medical interventions to prevent, manage, or treat a broad spectrum of physical, mental, and behavioural conditions.

In this audio interview, Gonçalo explains how this grant will fund ongoing work on Lesional Obsessive Compulsive Disorder (OCD) that is being developed in collaboration with several members of the Neuropsychiatry Unit. The proposal is to use the results from this work to test a new treatment for OCD through transcranial magnetic stimulation (TMS), which will include the Neuropsychiatry Unit’s first clinical trial using therapeutic TMS.
 

Listen to the full audio recording to find out more!